Exact Mass: 481.14198280000005
Exact Mass Matches: 481.14198280000005
Found 365 metabolites which its exact mass value is equals to given mass value 481.14198280000005
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Yersiniabactin
C21H27N3O4S3 (481.1163622000001)
A member of the class of thiazolidines that is (4S)-4-methyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid which is substituted at position 2 by a (1S)-1-hydroxy-1-{(4R)-2-[(4R)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl}-2-methylpropan-2-yl group. A siderophore found in the gram-negative bacterium species, Yersinia enterocolitica and Yersinia pestis. D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents
Talampicillin
C24H23N3O6S (481.13074980000005)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D08557
Pranlukast
C27H23N5O4 (481.17499580000003)
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DC - Leukotriene receptor antagonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent
Rosuvastatin
C22H28FN3O6S (481.16827600000005)
Rosuvastatin is an antilipemic agent that competitively inhibits hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reducuase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Rosuvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease. C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AA - Hmg coa reductase inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Pranlukast
C27H23N5O4 (481.17499580000003)
Pranlukast is only found in individuals that have used or taken this drug. It is a cysteinyl leukotriene receptor-1 antagonist. It antagonizes or reduces bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.Pranlukast selectively antagonizes leukotriene D4 (LTD4) at the cysteinyl leukotriene receptor, CysLT1, in the human airway. Pranlukast inhibits the actions of LTD4 at the CysLT1 receptor, preventing airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus.
(3R,5R)-7-[4-(4-Fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid
C22H28FN3O6S (481.16827600000005)
Pentanamide, N-(cyanomethyl)-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)ethyl)amino)-, (2S)-
C23H26F3N3O3S (481.1646882000001)
(3S)-3-[[(2S)-2-[[(2S)-2-Amino-3-methylbutanoyl]amino]propanoyl]-phenylmethoxycarbonylamino]-6-fluoro-4,5-dioxohexanoic acid
Benzyloxycarbonylvalyl-alanyl-aspartyl Fluoromethyl Ketone
Talampicillin
C24H23N3O6S (481.13074980000005)
Yersiniabactin
C21H27N3O4S3 (481.1163622000001)
2-(4-Methoxyphenyl)-2,2-dimethylethyl glucosinolate
C18H27NO10S2 (481.10763219999995)
6-Hydroxydelphinidin 3-glucoside
2,3-di(acetyloxy)-4-anilino-1-[1,2-di(acetyloxy)ethyl]-4-oxobutyl acetate
C22H27NO11 (481.15840320000007)
(1E)-5-methoxy-6-hydroxycinnamenyl-(1->6)-5,6-dihydrosanguinarine|maclekarpine E
(4Z)-5-{6-O-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]-beta-glucopyranosylsulfanyl}pent-4-enenitrile
C22H27NO9S (481.1406452000001)
Rosuvastatin
C22H28FN3O6S (481.16827600000005)
C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AA - Hmg coa reductase inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 2802
N2-(Pyrene-1-yl)methyl-deoxyguanosine
C27H23N5O4 (481.17499580000003)
Ala Cys Cys Trp
C20H27N5O5S2 (481.14535320000005)
Ala Cys Trp Cys
C20H27N5O5S2 (481.14535320000005)
Ala Asp Asn Tyr
C20H27N5O9 (481.1808692000001)
Ala Asp Tyr Asn
C20H27N5O9 (481.1808692000001)
Ala Asn Asp Tyr
C20H27N5O9 (481.1808692000001)
Ala Asn Tyr Asp
C20H27N5O9 (481.1808692000001)
Ala Trp Cys Cys
C20H27N5O5S2 (481.14535320000005)
Ala Tyr Asp Asn
C20H27N5O9 (481.1808692000001)
Ala Tyr Asn Asp
C20H27N5O9 (481.1808692000001)
Cys Ala Cys Trp
C20H27N5O5S2 (481.14535320000005)
Cys Ala Trp Cys
C20H27N5O5S2 (481.14535320000005)
Cys Cys Ala Trp
C20H27N5O5S2 (481.14535320000005)
Cys Cys Glu Lys
Cys Cys Glu Gln
C16H27N5O8S2 (481.13009819999996)
Cys Cys Lys Glu
Cys Cys Gln Glu
C16H27N5O8S2 (481.13009819999996)
Cys Cys Arg Thr
Cys Cys Thr Arg
Cys Cys Trp Ala
C20H27N5O5S2 (481.14535320000005)
Cys Asp Met Asn
C16H27N5O8S2 (481.13009819999996)
Cys Asp Asn Met
C16H27N5O8S2 (481.13009819999996)
Cys Glu Cys Lys
Cys Glu Cys Gln
C16H27N5O8S2 (481.13009819999996)
Cys Glu Lys Cys
Cys Glu Gln Cys
C16H27N5O8S2 (481.13009819999996)
Cys Lys Cys Glu
Cys Lys Glu Cys
Cys Met Asp Asn
C16H27N5O8S2 (481.13009819999996)
Cys Met Asn Asp
C16H27N5O8S2 (481.13009819999996)
Cys Met Gln Thr
Cys Met Thr Gln
Cys Asn Asp Met
C16H27N5O8S2 (481.13009819999996)
Cys Asn Met Asp
C16H27N5O8S2 (481.13009819999996)
Cys Gln Cys Glu
C16H27N5O8S2 (481.13009819999996)
Cys Gln Glu Cys
C16H27N5O8S2 (481.13009819999996)
Cys Gln Met Thr
Cys Gln Thr Met
Cys Arg Cys Thr
Cys Arg Thr Cys
Cys Ser Ser Trp
C20H27N5O7S (481.16311120000006)
Cys Ser Trp Ser
C20H27N5O7S (481.16311120000006)
Cys Thr Cys Arg
Cys Thr Met Gln
Cys Thr Gln Met
Cys Thr Arg Cys
Cys Trp Ala Cys
C20H27N5O5S2 (481.14535320000005)
Cys Trp Cys Ala
C20H27N5O5S2 (481.14535320000005)
Cys Trp Ser Ser
C20H27N5O7S (481.16311120000006)
Asp Ala Asn Tyr
C20H27N5O9 (481.1808692000001)
Asp Ala Tyr Asn
C20H27N5O9 (481.1808692000001)
Asp Cys Met Asn
C16H27N5O8S2 (481.13009819999996)
Asp Cys Asn Met
C16H27N5O8S2 (481.13009819999996)
Asp Phe Asn Ser
C20H27N5O9 (481.1808692000001)
Asp Phe Ser Asn
C20H27N5O9 (481.1808692000001)
Asp Gly Gln Tyr
C20H27N5O9 (481.1808692000001)
Asp Gly Tyr Gln
C20H27N5O9 (481.1808692000001)
Asp Met Cys Asn
C16H27N5O8S2 (481.13009819999996)
Asp Met Asn Cys
C16H27N5O8S2 (481.13009819999996)
Asp Asn Ala Tyr
C20H27N5O9 (481.1808692000001)
Asp Asn Cys Met
C16H27N5O8S2 (481.13009819999996)
Asp Asn Phe Ser
C20H27N5O9 (481.1808692000001)
Asp Asn Met Cys
C16H27N5O8S2 (481.13009819999996)
Asp Asn Ser Phe
C20H27N5O9 (481.1808692000001)
Asp Asn Tyr Ala
C20H27N5O9 (481.1808692000001)
Asp Gln Gly Tyr
C20H27N5O9 (481.1808692000001)
Asp Gln Tyr Gly
C20H27N5O9 (481.1808692000001)
Asp Ser Phe Asn
C20H27N5O9 (481.1808692000001)
Asp Ser Asn Phe
C20H27N5O9 (481.1808692000001)
Asp Tyr Ala Asn
C20H27N5O9 (481.1808692000001)
Asp Tyr Gly Gln
C20H27N5O9 (481.1808692000001)
Asp Tyr Asn Ala
C20H27N5O9 (481.1808692000001)
Asp Tyr Gln Gly
C20H27N5O9 (481.1808692000001)
Glu Cys Cys Lys
Glu Cys Cys Gln
C16H27N5O8S2 (481.13009819999996)
Glu Cys Lys Cys
Glu Cys Gln Cys
C16H27N5O8S2 (481.13009819999996)
Glu Gly Asn Tyr
C20H27N5O9 (481.1808692000001)
Glu Gly Tyr Asn
C20H27N5O9 (481.1808692000001)
Glu Lys Cys Cys
Glu Asn Gly Tyr
C20H27N5O9 (481.1808692000001)
Glu Asn Tyr Gly
C20H27N5O9 (481.1808692000001)
Glu Gln Cys Cys
C16H27N5O8S2 (481.13009819999996)
Glu Tyr Gly Asn
C20H27N5O9 (481.1808692000001)
Glu Tyr Asn Gly
C20H27N5O9 (481.1808692000001)
Phe Asp Asn Ser
C20H27N5O9 (481.1808692000001)
Phe Asp Ser Asn
C20H27N5O9 (481.1808692000001)
Phe Asn Asp Ser
C20H27N5O9 (481.1808692000001)
Phe Asn Ser Asp
C20H27N5O9 (481.1808692000001)
Phe Ser Asp Asn
C20H27N5O9 (481.1808692000001)
Phe Ser Asn Asp
C20H27N5O9 (481.1808692000001)
Gly Asp Gln Tyr
C20H27N5O9 (481.1808692000001)
Gly Asp Tyr Gln
C20H27N5O9 (481.1808692000001)
Gly Glu Asn Tyr
C20H27N5O9 (481.1808692000001)
Gly Glu Tyr Asn
C20H27N5O9 (481.1808692000001)
Gly Asn Glu Tyr
C20H27N5O9 (481.1808692000001)
Gly Asn Tyr Glu
C20H27N5O9 (481.1808692000001)
Gly Gln Asp Tyr
C20H27N5O9 (481.1808692000001)
Gly Gln Tyr Asp
C20H27N5O9 (481.1808692000001)
Gly Tyr Asp Gln
C20H27N5O9 (481.1808692000001)
Gly Tyr Glu Asn
C20H27N5O9 (481.1808692000001)
Gly Tyr Asn Glu
C20H27N5O9 (481.1808692000001)
Gly Tyr Gln Asp
C20H27N5O9 (481.1808692000001)
Lys Cys Cys Glu
Lys Cys Glu Cys
Lys Glu Cys Cys
Met Cys Asp Asn
C16H27N5O8S2 (481.13009819999996)
Met Cys Asn Asp
C16H27N5O8S2 (481.13009819999996)
Met Cys Gln Thr
Met Cys Thr Gln
Met Asp Cys Asn
C16H27N5O8S2 (481.13009819999996)
Met Asp Asn Cys
C16H27N5O8S2 (481.13009819999996)
Met Met Asn Ser
Met Met Ser Asn
Met Asn Cys Asp
C16H27N5O8S2 (481.13009819999996)
Met Asn Asp Cys
C16H27N5O8S2 (481.13009819999996)
Met Asn Met Ser
Met Asn Ser Met
Met Gln Cys Thr
Met Gln Thr Cys
Met Ser Met Asn
Met Ser Asn Met
Met Thr Cys Gln
Met Thr Gln Cys
Asn Ala Asp Tyr
C20H27N5O9 (481.1808692000001)
Asn Ala Tyr Asp
C20H27N5O9 (481.1808692000001)
Asn Cys Asp Met
C16H27N5O8S2 (481.13009819999996)
Asn Cys Met Asp
C16H27N5O8S2 (481.13009819999996)
Asn Asp Ala Tyr
C20H27N5O9 (481.1808692000001)
Asn Asp Cys Met
C16H27N5O8S2 (481.13009819999996)
Asn Asp Phe Ser
C20H27N5O9 (481.1808692000001)
Asn Asp Met Cys
C16H27N5O8S2 (481.13009819999996)
Asn Asp Ser Phe
C20H27N5O9 (481.1808692000001)
Asn Asp Tyr Ala
C20H27N5O9 (481.1808692000001)
Asn Glu Gly Tyr
C20H27N5O9 (481.1808692000001)
Asn Glu Tyr Gly
C20H27N5O9 (481.1808692000001)
Asn Phe Asp Ser
C20H27N5O9 (481.1808692000001)
Asn Phe Ser Asp
C20H27N5O9 (481.1808692000001)
Asn Gly Glu Tyr
C20H27N5O9 (481.1808692000001)
Asn Gly Tyr Glu
C20H27N5O9 (481.1808692000001)
Asn Met Cys Asp
C16H27N5O8S2 (481.13009819999996)
Asn Met Asp Cys
C16H27N5O8S2 (481.13009819999996)
Asn Met Met Ser
Asn Met Ser Met
Asn Ser Asp Phe
C20H27N5O9 (481.1808692000001)
Asn Ser Phe Asp
C20H27N5O9 (481.1808692000001)
Asn Ser Met Met
Asn Tyr Ala Asp
C20H27N5O9 (481.1808692000001)
Asn Tyr Asp Ala
C20H27N5O9 (481.1808692000001)
Asn Tyr Glu Gly
C20H27N5O9 (481.1808692000001)
Asn Tyr Gly Glu
C20H27N5O9 (481.1808692000001)
Gln Cys Cys Glu
C16H27N5O8S2 (481.13009819999996)
Gln Cys Glu Cys
C16H27N5O8S2 (481.13009819999996)
Gln Cys Met Thr
Gln Cys Thr Met
Gln Asp Gly Tyr
C20H27N5O9 (481.1808692000001)
Gln Asp Tyr Gly
C20H27N5O9 (481.1808692000001)
Gln Glu Cys Cys
C16H27N5O8S2 (481.13009819999996)
Gln Gly Asp Tyr
C20H27N5O9 (481.1808692000001)
Gln Gly Tyr Asp
C20H27N5O9 (481.1808692000001)
Gln Met Cys Thr
Gln Met Thr Cys
Gln Thr Cys Met
Gln Thr Met Cys
Gln Tyr Asp Gly
C20H27N5O9 (481.1808692000001)
Gln Tyr Gly Asp
C20H27N5O9 (481.1808692000001)
Arg Cys Cys Thr
Arg Cys Thr Cys
Arg Thr Cys Cys
Ser Cys Ser Trp
C20H27N5O7S (481.16311120000006)
Ser Cys Trp Ser
C20H27N5O7S (481.16311120000006)
Ser Asp Phe Asn
C20H27N5O9 (481.1808692000001)
Ser Asp Asn Phe
C20H27N5O9 (481.1808692000001)
Ser Phe Asp Asn
C20H27N5O9 (481.1808692000001)
Ser Phe Asn Asp
C20H27N5O9 (481.1808692000001)
Ser Met Met Asn
Ser Met Asn Met
Ser Asn Asp Phe
C20H27N5O9 (481.1808692000001)
Ser Asn Phe Asp
C20H27N5O9 (481.1808692000001)
Ser Asn Met Met
Ser Ser Cys Trp
C20H27N5O7S (481.16311120000006)
Ser Ser Trp Cys
C20H27N5O7S (481.16311120000006)
Ser Trp Cys Ser
C20H27N5O7S (481.16311120000006)
Ser Trp Ser Cys
C20H27N5O7S (481.16311120000006)
Thr Cys Cys Arg
Thr Cys Met Gln
Thr Cys Gln Met
Thr Cys Arg Cys
Thr Met Cys Gln
Thr Met Gln Cys
Thr Gln Cys Met
Thr Gln Met Cys
Thr Arg Cys Cys
Trp Ala Cys Cys
C20H27N5O5S2 (481.14535320000005)
Trp Cys Ala Cys
C20H27N5O5S2 (481.14535320000005)
Trp Cys Cys Ala
C20H27N5O5S2 (481.14535320000005)
Trp Cys Ser Ser
C20H27N5O7S (481.16311120000006)
Trp Ser Cys Ser
C20H27N5O7S (481.16311120000006)
Trp Ser Ser Cys
C20H27N5O7S (481.16311120000006)
Tyr Ala Asp Asn
C20H27N5O9 (481.1808692000001)
Tyr Ala Asn Asp
C20H27N5O9 (481.1808692000001)
Tyr Asp Ala Asn
C20H27N5O9 (481.1808692000001)
Tyr Asp Gly Gln
C20H27N5O9 (481.1808692000001)
Tyr Asp Asn Ala
C20H27N5O9 (481.1808692000001)
Tyr Asp Gln Gly
C20H27N5O9 (481.1808692000001)
Tyr Glu Gly Asn
C20H27N5O9 (481.1808692000001)
Tyr Glu Asn Gly
C20H27N5O9 (481.1808692000001)
Tyr Gly Asp Gln
C20H27N5O9 (481.1808692000001)
Tyr Gly Glu Asn
C20H27N5O9 (481.1808692000001)
Tyr Gly Asn Glu
C20H27N5O9 (481.1808692000001)
Tyr Gly Gln Asp
C20H27N5O9 (481.1808692000001)
Tyr Asn Ala Asp
C20H27N5O9 (481.1808692000001)
Tyr Asn Asp Ala
C20H27N5O9 (481.1808692000001)
Tyr Asn Glu Gly
C20H27N5O9 (481.1808692000001)
Tyr Asn Gly Glu
C20H27N5O9 (481.1808692000001)
Tyr Gln Asp Gly
C20H27N5O9 (481.1808692000001)
Tyr Gln Gly Asp
C20H27N5O9 (481.1808692000001)
silybin (mixture of silybin a and silybin b)
C25H21O10 (481.11346660000004)
3-Ethyl-5-methyl-4-(2-chlorophenyl)-2-(2,2-diethoxy-ethoxymethyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
Bifeprunox Mesylate
C25H27N3O5S (481.1671332000001)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Bifeprunox mesylate is a potent dopamine D2-like and 5-HT1A receptor partial agonist with pKis of 7.19 and 8.83 for cortex 5-HT1A and striatum D2, and a pEC50 of 6.37 for hippocampus 5-HT1A, respectively. Bifeprunox mesylate is an antipsychotic for the research of schizophrenia[1][2].
methyl 2-[[3-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-hydroxy-1-naphthyl]azo]benzoate
C26H19N5O5 (481.13861240000006)
1H-Pyrrolo[2,3-b]pyridine, 1-[(4-Methylphenyl)sulfonyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(2-thiazolyl)-
1-(METHOXYCARBONYL)-4-PIPERIDINECARBOXYLIC ACID
C23H29Cl2N3O4 (481.15350140000004)
6-[2-[6-(2-dimethylaminoethyl)-4-methoxy-benzo[1,3]dioxol-5-yl]acetyl]-2,3-dimethoxy-benzoic acid
C23H28ClNO8 (481.15033580000005)
Diethyl thiophosphoryl-(Z)-2-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl)isopropoxyiminoacetate
C17H28N3O7PS2 (481.11062280000004)
1-Biotinylamino-3,6,9-trioxaundecane-11-bromide
C18H32BrN3O5S (481.12459220000005)
(E)-7-(4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid
C22H28FN3O6S (481.16827600000005)
2-[[4-[(2,6-Dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]imino-3,4-dimethyl-5-thiazolecarboxylic acid ethyl ester
C21H27N3O6S2 (481.13412020000004)
(3r,5r,e)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid
C22H28FN3O6S (481.16827600000005)
Enloplatin [mart.]
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent > C1450 - Platinum Compound
Pentanamide, N-(cyanomethyl)-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)ethyl)amino)-, (2S)-
C23H26F3N3O3S (481.1646882000001)
Cefepime conjugate acid
C19H25N6O5S2+ (481.13277800000003)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DE - Fourth-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
Cbz-DL-Val-DL-Ala-DL-Asp-AcF
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors D009676 - Noxae > D000477 - Alkylating Agents > D000590 - Amino Acid Chloromethyl Ketones D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D020011 - Protective Agents
(3S)-3-[[(2S)-2-[[(2S)-2-Amino-3-methylbutanoyl]amino]propanoyl]-phenylmethoxycarbonylamino]-6-fluoro-4,5-dioxohexanoic acid
6-[5-[[(5-cyano-4-oxo-6-phenyl-1H-pyrimidin-2-yl)thio]methyl]-2-oxo-1,3-dihydroimidazol-4-yl]-6-oxohexanoic acid ethyl ester
C23H23N5O5S (481.14198280000005)
N-[1-[(4-bromoanilino)-oxomethyl]cyclohexyl]-N-(2-furanylmethyl)-2-pyridinecarboxamide
Arg-Thr-Cys-Cys
A tetrapeptide composed of L-arginine, L-threonine and two L-cysteine units joined in sequence by peptide linkages.
N-[2-[(2-furanylmethylamino)-oxomethyl]phenyl]-4-methyl-3-(1-piperidinylsulfonyl)benzamide
C25H27N3O5S (481.1671332000001)
4-[[1-[(3,4-Dichlorophenyl)methyl]-3-indolyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one
6-[4-Methyl-6-(4-nitrophenyl)-2-oxo-5-phenylmethoxycarbonyl-1,6-dihydropyrimidin-3-yl]hexanoic acid
C25H27N3O7 (481.18489120000004)
3-(1,3-benzodioxol-5-ylmethyl)-7-[1,4-dioxa-8-azaspiro[4.5]decan-8-yl(oxo)methyl]-2-sulfanylidene-1H-quinazolin-4-one
C24H23N3O6S (481.13074980000005)
5-methyl-4-[(5-methyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-(3-nitrophenyl)methyl]-2-phenyl-1H-pyrazol-3-one
C27H23N5O4 (481.17499580000003)
N-[3-[(2,4-dimethylphenyl)sulfamoyl]-4-methylphenyl]-3-oxo-4H-1,4-benzothiazine-6-carboxamide
C24H23N3O4S2 (481.11299180000003)
N-(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide
2-[(4-ethoxyphenyl)sulfonylamino]-N-[2-(4-morpholinyl)phenyl]benzamide
C25H27N3O5S (481.1671332000001)
Ethyl 4,5-dimethyl-2-[[2-(6-methyl-4-oxo-5-phenylthieno[2,3-d]pyrimidin-3-yl)acetyl]amino]thiophene-3-carboxylate
C24H23N3O4S2 (481.11299180000003)
N-[[(2S,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
C22H32BrN3O4 (481.15760520000003)
N-[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
C22H32BrN3O4 (481.15760520000003)
[2-[4-(2-Cyclohexylethyl)piperazin-1-yl]-2-oxoethyl] 4-methylsulfonyl-3-nitrobenzoate
C22H31N3O7S (481.18826160000003)
N-(3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-[[4-[3-(dimethylamino)propyl]-5-pyridin-4-yl-1,2,4-triazol-3-yl]thio]acetamide
3-(4-chlorophenyl)-1-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methylurea
C24H33Cl2N3O3 (481.1898848000001)
3-(4-chlorophenyl)-1-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methylurea
C24H33Cl2N3O3 (481.1898848000001)
3-(4-chlorophenyl)-1-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methylurea
C24H33Cl2N3O3 (481.1898848000001)
(1S,9R,10R,11R)-N-[(3,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-12-(pyrazine-2-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[[(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2R,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
2,2,2-trifluoro-N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H30F3N3O5S (481.18581660000007)
2,2,2-trifluoro-N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H30F3N3O5S (481.18581660000007)
2,2,2-trifluoro-N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H30F3N3O5S (481.18581660000007)
2,2,2-trifluoro-N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H30F3N3O5S (481.18581660000007)
N-[(3-fluorophenyl)methyl]-2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide
C23H23F4N3O4 (481.16246060000003)
N-[(3-fluorophenyl)methyl]-2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide
C23H23F4N3O4 (481.16246060000003)
N-[(3-fluorophenyl)methyl]-2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide
C23H23F4N3O4 (481.16246060000003)
1-[(2R,3S,6R)-6-[2-[(2-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(4-methoxyphenyl)urea
C22H28FN3O6S (481.16827600000005)
1-[(2R,3R,6R)-6-[2-[(2-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(4-methoxyphenyl)urea
C22H28FN3O6S (481.16827600000005)
1-[(2S,3S,6R)-6-[2-[(2-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(4-methoxyphenyl)urea
C22H28FN3O6S (481.16827600000005)
1-(3-chlorophenyl)-3-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[(2-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]urea
C22H28ClN3O5S (481.1438108000001)
3-(4-chlorophenyl)-1-[(2S,3R)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methylurea
C24H33Cl2N3O3 (481.1898848000001)
3-(4-chlorophenyl)-1-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methylurea
C24H33Cl2N3O3 (481.1898848000001)
(1R,9S,10S,11S)-N-[(3,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-12-(pyrazine-2-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[[(2R,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2S,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2S,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide
N-[[(2S,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
C22H32BrN3O4 (481.15760520000003)
N-[[(2R,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
C22H32BrN3O4 (481.15760520000003)
N-[[(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
C22H32BrN3O4 (481.15760520000003)
N-[[(2R,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
C22H32BrN3O4 (481.15760520000003)
N-[[(2S,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
C22H32BrN3O4 (481.15760520000003)
N-[[(2S,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide
C22H32BrN3O4 (481.15760520000003)
2,2,2-trifluoro-N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H30F3N3O5S (481.18581660000007)
2,2,2-trifluoro-N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H30F3N3O5S (481.18581660000007)
2,2,2-trifluoro-N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H30F3N3O5S (481.18581660000007)
2,2,2-trifluoro-N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H30F3N3O5S (481.18581660000007)
2,2,2-trifluoro-N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H30F3N3O5S (481.18581660000007)
2,2,2-trifluoro-N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H30F3N3O5S (481.18581660000007)
2,2,2-trifluoro-N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]ethanesulfonamide
C20H30F3N3O5S (481.18581660000007)
N-[(3-fluorophenyl)methyl]-2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide
C23H23F4N3O4 (481.16246060000003)
N-[(3-fluorophenyl)methyl]-2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide
C23H23F4N3O4 (481.16246060000003)
N-[(3-fluorophenyl)methyl]-2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide
C23H23F4N3O4 (481.16246060000003)
N-[(3-fluorophenyl)methyl]-2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide
C23H23F4N3O4 (481.16246060000003)
N-[(3-fluorophenyl)methyl]-2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide
C23H23F4N3O4 (481.16246060000003)
1-[(2S,3R,6S)-6-[2-[(2-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(4-methoxyphenyl)urea
C22H28FN3O6S (481.16827600000005)
1-[(2S,3R,6R)-6-[2-[(2-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(4-methoxyphenyl)urea
C22H28FN3O6S (481.16827600000005)
1-[(2S,3S,6S)-6-[2-[(2-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(4-methoxyphenyl)urea
C22H28FN3O6S (481.16827600000005)
1-[(2R,3S,6S)-6-[2-[(2-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(4-methoxyphenyl)urea
C22H28FN3O6S (481.16827600000005)
1-[(2R,3R,6S)-6-[2-[(2-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(4-methoxyphenyl)urea
C22H28FN3O6S (481.16827600000005)
3-(4-chlorophenyl)-1-[(2R,3S)-4-[(2-chlorophenyl)methyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methylurea
C24H33Cl2N3O3 (481.1898848000001)
3-(4-chlorophenyl)-1-[(2S,3S)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methylurea
C24H33Cl2N3O3 (481.1898848000001)
3-(4-chlorophenyl)-1-[(2R,3R)-4-[(2-chlorophenyl)methyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-1-methylurea
C24H33Cl2N3O3 (481.1898848000001)
(6R,7S)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
C19H25N6O5S2+ (481.13277800000003)
(3-oxo-1H-2-benzofuran-1-yl) (2S,5S,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
C24H23N3O6S (481.13074980000005)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-methoxybenzoate
C18H20N5O9P (481.0998600000001)
9-[(2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-(pyren-1-ylmethylamino)-1H-purin-6-one
C27H23N5O4 (481.17499580000003)
GSK598809
GSK598809 is a potent and selective dopamine D3 Receptor (DRD3) antagonist, with a pKi of 8.9.
SQLE-IN-1
SQLE-IN-1 (compound 19) is a squalene epoxidase (SQLE) inhibitor. SQLE-IN-1 inhibits the proliferation and migration of Huh7 cells. SQLE-IN-1 inhibits the cell cholesterol generation. SQLE-IN-1 increases the expression of PTEN and inhibits PI3K and AKT[1]. SQLE-IN-1 (compound 19) is a squalene epoxidase (SQLE) inhibitor. SQLE-IN-1 inhibits the proliferation and migration of Huh7 cells. SQLE-IN-1 inhibits the cell cholesterol generation. SQLE-IN-1 increases the expression of PTEN and inhibits PI3K and AKT[1].
UC2288
C20H18ClF6N3O2 (481.09916699999997)
UC2288 is a novel, cell-permeable, and orally active p21 attenuator (relatively selective activity for p21), which is synthesized based Sorafenib (HY-10201). UC2288 decreases p21 mRNA expression independently of p53, and attenuates p21 protein levels with minimal effect on p21 protein stability. UC2288 has no inhibition of VEGFR2 and Raf kinases even at 10 μM[1].
(r)-{[(2s,4s)-2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)butylidene]amino}[(2s,3s,4s,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid
4-(hydroxymethyl)-5,6-dimethoxy-3-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-4,8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-undecaen-18-ol
C28H23N3O5 (481.16376280000003)
{[2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)butylidene]amino}[5-(4-formyl-2-hydroxyimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]acetic acid
2-methoxy-4-[(1e)-2-[(23r)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-yl]ethenyl]phenol
(4s)-2-[(1s)-1-hydroxy-2-methyl-1-[(4r)-2-[(4r)-2-[(1e)-6-oxocyclohexa-2,4-dien-1-ylidene]-1,3-thiazolidin-4-yl]-1,3-thiazolidin-4-yl]propan-2-yl]-4-methyl-5h-1,3-thiazole-4-carboxylic acid
C21H27N3O4S3 (481.1163622000001)
(2r,6s)-4-(hydroxymethyl)-5,6-dimethoxy-3-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-4,8(13),9,11,14(28),15(19),17,20(27),21(26),22,24-undecaen-18-ol
C28H23N3O5 (481.16376280000003)
5,6,7-trihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-1λ⁴-chromen-1-ylium
(4s)-2-[(1s)-1-hydroxy-1-[(2r,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl]-2-methylpropan-2-yl]-4-methyl-5h-1,3-thiazole-4-carboxylic acid
C21H27N3O4S3 (481.1163622000001)
(r)-{[(2r,4s)-2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)butylidene]amino}[(2s,3r,4s,5r)-5-(4-formyl-2-hydroxyimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]acetic acid
(10s)-10-{[(2s,4s,5s,6s)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-8-ethyl-1,6,11-trihydroxy-9,10-dihydrotetracene-5,12-dione
C26H27NO8 (481.17365820000003)
(4r)-2-[(1s)-1-hydroxy-1-[(2r,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl]-2-methylpropan-2-yl]-4-methyl-5h-1,3-thiazole-4-carboxylic acid
C21H27N3O4S3 (481.1163622000001)
2,21-dimethyl (1s,12r,19r,21s,24s)-24-cyano-21-hydroxy-5,7-dioxa-2,15-diazaheptacyclo[17.2.2.1¹²,¹⁵.0¹,¹².0³,¹¹.0⁴,⁸.0¹⁹,²⁴]tetracosa-3(11),4(8),9-triene-2,21-dicarboxylate
C25H27N3O7 (481.18489120000004)
10-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-8-ethyl-1,6,11-trihydroxy-9,10-dihydrotetracene-5,12-dione
C26H27NO8 (481.17365820000003)
(1's,3r,3's,7's)-5-chloro-2,13'-dihydroxy-4',4',7,7-tetramethyl-9',14'-diazaspiro[chromeno[5,6-b]pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-en-8'-one
C26H28ClN3O4 (481.1768238000001)
{[2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)butylidene]amino}[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid
5-chloro-2,13'-dihydroxy-4',4',7,7-tetramethyl-9',14'-diazaspiro[chromeno[5,6-b]pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-en-8'-one
C26H28ClN3O4 (481.1768238000001)
(4s)-2-(1-hydroxy-1-{2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl}-2-methylpropan-2-yl)-4-methyl-5h-1,3-thiazole-4-carboxylic acid
C21H27N3O4S3 (481.1163622000001)